Preliminary study finds that Ebola virus fragments can persist in the semen of some survivors for at least nine months

Preliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms. The report, published today in the New England Journal of Medicine, provides…

Continue ReadingPreliminary study finds that Ebola virus fragments can persist in the semen of some survivors for at least nine months

WHO news release: Treat all people living with HIV, offer antiretrovirals as additional prevention choice for people at “substantial” risk

30 September 2015: Geneva -Anyone infected with HIV should begin antiretroviral treatment as soon after diagnosis as possible, the World Health Organization (WHO) announced Wednesday. With its "treat-all" recommendation, WHO removes all limitations on eligibility for antiretroviral therapy (ART) among people living with HIV; all…

Continue ReadingWHO news release: Treat all people living with HIV, offer antiretrovirals as additional prevention choice for people at “substantial” risk

Vaccine hesitancy: A growing challenge for immunization programmes

GENEVA: 18 AUGUST 2015 - People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, one in 5 children still do not receive routine life-saving immunizations, and an estimated 1.5…

Continue ReadingVaccine hesitancy: A growing challenge for immunization programmes

WHO issues rapid health assessment on impact of Nepal earthquake

  • Post category:AllHealth

A rapid assessment of health-care facilities by the World Health Organization (WHO) and the Ministry of Health and Population in the earthquake-stricken areas has found that hospitals in 4 of the worst-affected districts are completely destroyed or too badly damaged to function.  Five other major…

Continue ReadingWHO issues rapid health assessment on impact of Nepal earthquake

WHO welcomes Swissmedic approval of Ebola vaccine trial at Lausanne University Hospital

Geneva: 28 October 2014: The World Health Organization (WHO) welcomes the approval by Swissmedic, the Swiss regulatory authority for therapeutic products, for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). This marks the latest step towards bringing safe and effective…

Continue ReadingWHO welcomes Swissmedic approval of Ebola vaccine trial at Lausanne University Hospital

End of content

No more pages to load